Treating Neuroblastoma with Crizotinib
Neuroblastoma treatment is advanced through a study of ALK mutation sensitivities to the anti-cancer drug crizotinib. Drs. Mossé and Mark Lemmon were study co-leaders.
Neuroblastoma treatment is advanced through a study of ALK mutation sensitivities to the anti-cancer drug crizotinib. Drs. Mossé and Mark Lemmon were study co-leaders.